18 reports

  • VI. Glenmark Pharmaceuticals Limited
  • Isotretinoin Drugs for Acne Treatments Type

Acne vulgaris, also known as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common disorders...

  • Acne Treatment
  • Dermatological Condition
  • Pharmaceutical
  • Allergan plc
  • Glenmark Pharmaceuticals Ltd.
  • GLENMARK PHARMACEUTICALS
  • PAT AND CURRENT RATIO, BY MEDIUM SIZE NEUROPSYCHIATRIC MARKET PLAYERS

Executive Summary The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders. Indian Neuropsychiatry Market is a growing market with key players holding dominant positions. The report is classified on the...

  • Neurology
  • Pharmaceutical
  • Alembic Ltd
  • Glenmark Pharmaceuticals Ltd.
  • Sanofi S.A.
  • GLENMARK PHARMA ENTERS INTO LICENSING AGREEMENT WITH ELITE PHARMA
  • ELITE PHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

Summary Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products.The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Application (NDA) for the treatment...

  • Opioid
  • Pharmaceutical
  • United States
  • Company
  • Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details
  • GLENMARK PHARMA ENTERS INTO LICENSING AGREEMENT WITH CYNDEA PHARMA

Summary Glenmark Pharmaceuticals Ltd (Glenmark) is a pharmaceutical company which focuses on the discovery of new chemical entities (NCEs) and new biological entities (NBEs).The company’s formulations business encompasses therapeutic areas such as dermatology, anti-infective, respiratory, central nervous system, and oncology. It...

  • Pharmaceutical
  • United States
  • Company Financials
  • Supply
  • Glenmark Pharmaceuticals Ltd.
  • SUMMARY ANALYSIS: Glenmark Pharmaceuticals Ltd
  • Leverage Analysis: Glenmark Pharmaceuticals Ltd

A textual analysis of the financial results for Glenmark Pharmaceuticals Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Pharmaceutical
  • India
  • World
  • Company Financials
  • Glenmark Pharmaceuticals Ltd.

ROCHE (GENENTECH & CHUGAI PHARMACEUTICAL CO) - ##/ ## ## ## Emicizumab; RG##; ACE##; hBS## ID No.

  • Biological Therapy
  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.

ROCHE (GENENTECH & CHUGAI PHARMACEUTICAL CO) - ##/ ## ## ## Emicizumab; RG##; ACE##; hBS## ID No.

  • Biological Therapy
  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.
  • GLENMARK PHARMACEUTICALS LIMITED
  • TARGET: BIOVENA PHARMA SP. Z O.O. - 7 PHARMACEUTICAL BRANDS - POLAND

Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Glenmark Pharmaceuticals Ltd.
  • GLENMARK PHARMACEUTICALS LIMITED
  • TARGET: BIOVENA PHARMA SP. Z O.O. - 7 PHARMACEUTICAL BRANDS - POLAND

Glenmark Pharmaceuticals Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Glenmark Pharmaceuticals Ltd.
  • GLENMARK PHARMACEUTICALS
  • ID No. Name

Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies – 2016 Update This Competitive Intelligence Report about Biosimilar and Biosuperior Anti-Her2 Antibodies 2016 updates the competitive landscape of biosimilar and biosuperior therapeutic antibodies targeting Her2 in comparison with originator...

  • Pharmaceutical
  • Therapy
  • Genentech, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Roche Group
  • TECHNOLOGY AND PHARMA COMPANIES WITH RORGAMMA MODULATOR R&D
  • RORGAMMA(T) ANTAGONISTS / INVERSE AGONISTS DISCOVERY PROGRAMS

RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug discovery and development. Technology companies...

  • Autoimmune Disease
  • Pharmaceutical
  • 4SC Discovery GmbH
  • Advinus
  • Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details
  • Glenmark Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Glenmark Pharmaceuticals Inc USA (Glenmark Pharmaceuticals), formerly Glenmark Generics Inc USA, a subsidiary of Glenmark Pharmaceuticals Ltd, is a manufacturer of generic pharmaceutical products.The company’s products include acamprosate calcium delayed release tablets, adapalene gel, alclometasone dipropionate...

  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. Snapshot
  • Glenmark Pharmaceuticals Ltd., Subsidiaries

Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - 2016’, provides an overview of the Glenmark Pharmaceuticals Ltd.’s pharmaceutical research and development focus. The report provides comprehensive information...

  • Pharmaceutical
  • India
  • United States
  • Company Operations
  • Glenmark Pharmaceuticals Ltd.
  • GLENMARK PHARMACEUTICALS
  • Bi- and Multispecific Her2 Antibody Pipeline - 1/6

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and...

  • Pharmaceutical
  • Therapy
  • Genentech, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Roche Group
  • GLENMARK PHARMACEUTICALS LTD.
  • CHRONIC COUGH - PIPELINE BY GLENMARK PHARMACEUTICALS LTD., H1 2016

Chronic Cough - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chronic Cough - Pipeline Review, H1 2016’, provides an overview of the Chronic Cough pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Cough, complete with analysis by stage...

  • Pharmaceutical
  • United States
  • Company Operations
  • Product Initiative
  • Glenmark Pharmaceuticals Ltd.
  • Industry
  • Stock exchange

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Glenmark Generics, Inc.'s contact information and...

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Glenmark Pharmaceuticals Ltd.
  • Stock exchange
  • Industry

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Glenmark Generics, Ltd.'s contact information and...

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Glenmark Pharmaceuticals Ltd.
  • INFECTIOUS DIARRHEA THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY GLENMARK PHARMACEUTICALS LTD.,
  • Prominent Sponsors

Infectious Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H1, 2015" provides data on the Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.